Design, synthesis, molecular docking, and antimicrobial evaluation of hybrid peptides incorporating unnatural amino acids with enhanced hydrophobic sidechains
Open Access
- 20 February 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (12) , 11090-11099
Abstract
The emergence of multidrug-resistant (MDR) pathogens has intensified the need for novel antimicrobial agents. This study focuses on the design, synthesis, and evaluation of hybrid peptides (6a–6e) incorporating unnatural amino acids featuring enhanced hydrophobic side chains. These peptides, particularly 6e, demonstrated potent antimicrobial efficacy. Molecular docking identified the robust binding affinities of peptides 6e and 6b towards the transglycosylase domain of Escherichia coli PBP1b, indicating their potential as enzyme inhibitors. Molecular dynamics (MD) simulations confirmed the stability of peptide-protein complexes over a 100 ns timespan, supporting the structural integrity of peptide 6e. Experimental data further validated computational predictions, with peptide 6e exhibiting minimum inhibitory concentrations (MICs) as low as 2 µg mL−1 against E. coli and 0.2 µg mL−1 against Bacillus subtilis. Additionally, 6e demonstrated broad-spectrum antifungal efficacy, showing competitive activity against Candida albicans and Aspergillus niger. These results establish unnatural amino acid-based peptides as promising candidates in addressing MDR infections, warranting further studies for clinical application.Keywords
Funding Information
- King Faisal University (KFU254414)
This publication has 59 references indexed in Scilit:
- Exploring MDR‐TB Inhibitory Potential of 4‐Aminoquinazolines as Mycobacterium tuberculosis N‐Acetylglucosamine‐1‐Phosphate Uridyltransferase (GlmUMTB) InhibitorsChemistry & Biodiversity, 2020
- Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteriaEuropean Journal of Pharmaceutical Sciences, 2020
- Induced conformational changes activate the peptidoglycan synthase PBP1BMolecular Microbiology, 2018
- Exploring the role of unnatural amino acids in antimicrobial peptidesScientific Reports, 2018
- Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1BJournal of Biological Chemistry, 2017
- C-terminal Lysine-Linked Magainin 2 with Increased Activity Against Multidrug-Resistant BacteriaProtein & Peptide Letters, 2016
- Influence of lipidation on the mode of action of a small RW-rich antimicrobial peptideBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- Activities and regulation of peptidoglycan synthasesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2015
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptidesBiomaterials, 2012